CD40 and Its Ligand in Autoimmimity
- 1 April 1997
- journal article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 815 (1), 384-390
- https://doi.org/10.1111/j.1749-6632.1997.tb52089.x
Abstract
No abstract availableThis publication has 32 references indexed in Scilit:
- IMMUNE REGULATION BY CD40 AND ITS LIGAND GP39Annual Review of Immunology, 1996
- Impairment of antigen-specific T-cell priming in mice lacking CD40 ligandNature, 1995
- Activated T cells enhance nitric oxide production by murine splenic macrophages through gp39 and LFA‐1European Journal of Immunology, 1995
- Antibody to the ligand of CD40, gp39, blocks the occurrence of the acute and chronic forms of graft-vs-host disease.JCI Insight, 1994
- Mice deficient for the CD40 ligandImmunity, 1994
- CD40 and its ligand, an essential ligand-receptor pair for thymus-dependent B-cell activationImmunology Today, 1992
- Identification of a source of biologically active CD40 ligandEuropean Journal of Immunology, 1992
- Molecular and biological characterization of a murine ligand for CD40Nature, 1992
- Activation of human B lymphocytes through CD40 and interleukin 4European Journal of Immunology, 1989
- Synergistic interaction between interleukin 4 and anti-Bp50 (CDw40) revealed in a novel B cell restimulation assayEuropean Journal of Immunology, 1987